These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11841962)

  • 1. Endocrine sequelae in survivors of childhood cancer.
    Oberfield SE; Sklar CA
    Adolesc Med; 2002 Feb; 13(1):161-9, viii. PubMed ID: 11841962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine complications in long-term survivors of childhood cancers.
    Chemaitilly W; Sklar CA
    Endocr Relat Cancer; 2010 Sep; 17(3):R141-59. PubMed ID: 20453080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for late effects in survivors of childhood cancer: growth hormone deficiency from a pediatric oncologist's point of view.
    van den Bos C; Heinen RC; Sukel M; van der Pal HJ; Geenen MM
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S125-8. PubMed ID: 15135793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine consequences of childhood malignancies.
    Karachaliou F; Simatos G; Batika P; Michalacos S; Kaldrymides P
    J BUON; 2009; 14(1):27-32. PubMed ID: 19373943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.
    Gleeson HK; Darzy K; Shalet SM
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):335-48. PubMed ID: 12064896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term endocrine sequelae of childhood cancer.
    Rutter MM; Rose SR
    Curr Opin Pediatr; 2007 Aug; 19(4):480-7. PubMed ID: 17630615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring after childhood cancer--an update for GPs.
    Heath JA
    Aust Fam Physician; 2005 Sep; 34(9):761-7. PubMed ID: 16184209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours.
    Gleeson HK; Shalet SM
    Endocr Relat Cancer; 2004 Dec; 11(4):589-602. PubMed ID: 15613441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
    Thomas-Teinturier C; Salenave S
    Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.
    Wasilewski-Masker K; Kaste SC; Hudson MM; Esiashvili N; Mattano LA; Meacham LR
    Pediatrics; 2008 Mar; 121(3):e705-13. PubMed ID: 18310191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine complications of childhood cancer therapy: evaluation and management.
    Haller MJ; Schatz DA
    Pediatr Endocrinol Rev; 2007 Mar; 4(3):196-204. PubMed ID: 17551480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
    Spoudeas HA; Charmandari E; Brook CG
    Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does growth hormone cause cancer?
    Jenkins PJ; Mukherjee A; Shalet SM
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):115-21. PubMed ID: 16430706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The late endocrine effects of childhood cancer treatment.
    Brougham MF; Kelnar CJ; Wallace WH
    Pediatr Rehabil; 2002; 5(4):191-201. PubMed ID: 12745898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.
    Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM
    Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group.
    Nandagopal R; Laverdière C; Mulrooney D; Hudson MM; Meacham L
    Horm Res; 2008; 69(2):65-74. PubMed ID: 18059086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term endocrine complications after brain tumor treatment--own experience].
    Wójcik M; Dolezal-Ołtarzewska K; Kumorowicz-Czoch M; Kalicka-Kasperczyk A; Januś D; Zygmunt-Górska A; Wojtyś J; Korab-Chrzanowska E; Kwiatkowski S; Starzyk J
    Przegl Lek; 2010; 67(11):1132-5. PubMed ID: 21442963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survivors of childhood cancers: what knowledge have we gained?
    Hawkins MM
    Nat Clin Pract Oncol; 2004 Nov; 1(1):26-31. PubMed ID: 16264796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late morbidity after successful treatment of children with cancer.
    Bhatia S; Constine LS
    Cancer J; 2009; 15(3):174-80. PubMed ID: 19556899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.